Literature DB >> 33047160

Response to single oral dose vitamin D in obese vs non-obese vitamin D-deficient children.

Akshay Tayde1, Medha Mittal2, Rajesh Khadgawat3, Shikha Sharma4, V Sreenivas5, Anuradha Rai1.   

Abstract

Obese individuals are prone to vitamin D deficiency because of sequestration of vitamin D in their body fat. We planned to evaluate the rise in serum 25(OH)D levels in vitamin D-deficient obese vs normal body mass index(BMI) children, after administration of identical single dose of vitamin D. Twenty-two obese and 22 normal BMI children with serum 25 (OH)D < 20 ng/mL were given single oral dose 150,000 IU vitamin D, and 25 (OH)D levels were measured at 1 week and 1 month post-intervention. Results show that rise in 25(OH)D level from baseline was about 2.2 times lesser in obese compared with children with normal BMI, both at 1 week and at 1 month. The rise in 25(OH)D from baseline to 1 month was inversely correlated to BMI (r = - 0.56, p = < 0.001), waist circumference (r = - 0.48, p = 0.001), total fat mass (r = - 0.58, p < 0.001), and fat mass index (r = - 0.59, p < 0.001).
Conclusion: The obese children have a 2.2 times lower rise in serum vitamin D levels as compared with the normal BMI children for the same dose of vitamin D supplementation. What is Known: • The obese individuals are prone to vitamin D deficiency and may be given higher doses of vitamin D supplementation. What is New: • Our study demonstrates that obese children have 2.2 times lesser rise in serum 25(OH)D concentrations as compared with normal BMI children when administered similar oral dose vitamin D.

Entities:  

Keywords:  25(OH)D; BMI; Deficiency; Fat mass; Obese; Vitamin D

Mesh:

Substances:

Year:  2020        PMID: 33047160     DOI: 10.1007/s00431-020-03831-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  2 in total

1.  Serum 25-hydroxyvitamin D (25-OH-D) in obese adolescents.

Authors:  Barbara Garanty-Bogacka; Małgorzata Syrenicz; Joanna Goral; Beata Krupa; Justyna Syrenicz; Mieczysław Walczak; Anhelli Syrenicz
Journal:  Endokrynol Pol       Date:  2011       Impact factor: 1.582

2.  Elevated serum level of human alkaline phosphatase in obesity.

Authors:  Abdul Rehman Khan; Fazli Rabbi Awan; Syeda Sadia Najam; Mehboob Islam; Tehmina Siddique; Maryam Zain
Journal:  J Pak Med Assoc       Date:  2015-11       Impact factor: 0.781

  2 in total
  2 in total

Review 1.  Drug dosing in children with obesity: a narrative updated review.

Authors:  Francesca Gaeta; Valeria Conti; Angela Pepe; Pietro Vajro; Amelia Filippelli; Claudia Mandato
Journal:  Ital J Pediatr       Date:  2022-09-08       Impact factor: 3.288

Review 2.  Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?

Authors:  John P Bilezikian; Anna Maria Formenti; Robert A Adler; Neil Binkley; Roger Bouillon; Marise Lazaretti-Castro; Claudio Marcocci; Nicola Napoli; Rene Rizzoli; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2021-12-23       Impact factor: 6.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.